A Study to Evaluate the Safety of Escalating Doses of Ocrelizumab in Subjects With Rheumatoid Arthritis
Clinical trial NCT00077870 · COMPLETED
Trial details
- NCT number
- NCT00077870
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Enrollment
- 237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.